Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enabling time-aware treatment plan evaluation for clinical proton pencil beam scanning systems.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer.

Physics and imaging in radiation oncology·2026
Same author

An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy.

Physics and imaging in radiation oncology·2026
Same author

Investigation of compact multi-layer ionization chamber detector designs for quality control of CBCT-based synthetic CTs for adaptive proton therapy.

Physics in medicine and biology·2025
Same author

Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

Acta oncologica (Stockholm, Sweden)·2025
Same author

Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024

Related Experiment Video

Updated: Dec 20, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

Consensus Statement on Proton Therapy in Mesothelioma.

Jing Zeng1, Shahed N Badiyan2, Yolanda I Garces3

  • 1Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.

Practical Radiation Oncology
|May 29, 2020
PubMed
Summary
This summary is machine-generated.

Proton therapy offers improved normal tissue sparing for mesothelioma patients, significantly reducing radiation dose to organs like the contralateral lung. However, challenges in thoracic treatment planning require further research.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.2K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K

Related Experiment Videos

Last Updated: Dec 20, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.2K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Thoracic Oncology

Background:

  • Mesothelioma treatment with radiation therapy is limited by normal tissue toxicity, particularly to the contralateral lung.
  • Proton therapy's physical properties offer potential advantages in sparing healthy tissues in the thoracic region.

Purpose of the Study:

  • To review the clinical data on proton therapy for mesothelioma.
  • To outline the indications, advantages, and limitations of proton therapy in this context.

Main Methods:

  • Review of existing clinical data and guidelines for proton therapy in mesothelioma.
  • Analysis of dose reduction benefits and treatment challenges.

Main Results:

  • Proton therapy demonstrates significant dose reductions to organs at risk, including the contralateral lung, heart, liver, kidneys, and stomach.
  • Guidelines for proton therapy use in mesothelioma have been developed by the Particle Therapy Cooperative Group Thoracic Subcommittee.

Conclusions:

  • Proton therapy presents a promising approach for mesothelioma radiation, with superior normal tissue sparing compared to photons.
  • Addressing challenges such as tissue heterogeneity, organ motion, and anatomical changes is crucial for optimizing proton therapy outcomes.